| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |